« Previous
Next »
American Journal of Ophthalmology
Volume 143, Issue 4
, Pages
566-583.e2
, April 2007
An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration
To access this article, please choose from the options below
See accompanying Editorial on page 679.
PII: S0002-9394(07)00068-2
doi: 10.1016/j.ajo.2007.01.028
© 2007 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Ophthalmology
Volume 143, Issue 4
, Pages
566-583.e2
, April 2007
